Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 2, 2008, Pages 563-572

  Pfister, Lukas A ^a   Alther, Eva ^a   Papaloïzos, Michaël ^b   Merkle, Hans P ^a   Gander, Bruno ^a  

^a Institute of Pharmaceutical Sciences   (Switzerland)

^b Center for Hand Surgery and Therapy   (Switzerland)

Author keywords

Nerve conduit; Nerve regeneration; NGF; Release kinetics

Indexed keywords

ACETIC ACID; ALGINIC ACID; CHITOSAN; CITRIC ACID; NERVE GROWTH FACTOR; POLYELECTROLYTE; POLYGLACTIN; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; DRUG RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENT; IMPLANTATION; IN VITRO STUDY; INTROSPECTION; KINETICS; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE; PH; RAT; REPRODUCIBILITY; SUSTAINED DRUG RELEASE;

ALGINATES; ANIMALS; BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROGELS; KINETICS; NERVE GROWTH FACTORS; PC12 CELLS; RATS;

EID: 43249108315     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.01.014     Document Type: Article

References (28)

1. Jaquet J.B., Luijsterburg A.J., Kalmijn S., Kuypers P.D., Hofman A., and Hovius S.E. Median, ulnar, and combined median-ulnar nerve injuries: functional outcome and return to productivity. J. Trauma 51 (2001) 687-692
2. Kim D.H., Han K., Tiel R.L., Murovic J.A., and Kline D.G. Surgical outcomes of 654 ulnar nerve lesions. J. Neurosurg. 98 (2003) 993-1004
3. Belkas J.S., Shoichet M.S., and Midha R. Peripheral nerve regeneration through guidance tubes. Neurol. Res. 26 (2004) 151-160
4. Bellamkonda R.V. Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy. Biomaterials 27 (2006) 3515-3518
5. Meek M.F., and Coert J.H. Clinical use of nerve conduits in peripheral-nerve repair: review of the literature. J. Reconstr. Microsurg. 18 (2002) 97-109
6. Strauch B. Use of nerve conduits in peripheral nerve repair. Hand Clin. 16 (2000) 123-130
7. Taras J.S., Nanavati V., and Steelman P. Nerve conduits. J. Hand Ther. 18 (2005) 191-197
8. Archibald S.J., Shefner J., Krarup C., and Madison R.D. Monkey median nerve repaired by nerve graft or collagen nerve guide tube. J. Neurosci. 15 (1995) 4109-4123
9. Krarup C., Archibald S.J., and Madison R.D. Factors that influence peripheral nerve regeneration: an electrophysiological study of the monkey median nerve. Ann. Neurol. 51 (2002) 69-81
10. Battiston B., Geuna S., Ferrero M., and Tos P. Nerve repair by means of tubulization: literature review and personal clinical experience comparing biological and synthetic conduits for sensory nerve repair. Microsurgery 25 (2005) 258-267
11. Fu S.Y., and Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol. Neurobiol. 14 (1997) 67-116
12. Frostick S.P., Yin Q., and Kemp G.J. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 18 (1998) 397-405
13. Apfel S.C. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol. 9 (1999) 393-413
14. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 194 (1999) 1-14
15. Pfister L.A., Papaloizos M., Merkle H.P., and Gander B. Nerve conduits and growth factor delivery in peripheral nerve repair. J. Peripher. Nerv. Syst. 12 (2007) 65-82
16. Whittlesey K.J., and Shea L.D. Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface. Exp. Neurol. 190 (2004) 1-16
17. Wang L., Khor E., Wee A., and Lim L.Y. Chitosan-alginate PEC membrane as a wound dressing: assessment of incisional wound healing. J. Biomed. Mater. Res. 63 (2002) 610-618
18. Li Z., Ramay H.R., Hauch K.D., Xiao D., and Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 26 (2005) 3919-3928
19. Li Z., and Zhang M. Chitosan-alginate as scaffolding material for cartilage tissue engineering. J. Biomed. Mater. Res. A 75 (2005) 485-493
20. Nguyen C.B., Szonyi E., Sadick M.D., Hotaling T.E., Mendoza-Ramirez J.L., and Escandon E. Stability and interactions of recombinant human nerve growth factor in different biological matrices: in vitro and in vivo studies. Drug Metab. Dispos. 28 (2000) 590-597
21. Okragly A.J., and Haak-Frendscho M. An acid-treatment method for the enhanced detection of GDNF in biological samples. Exp. Neurol. 145 (1997) 592-596
22. Lam X.M., Duenas E.T., and Cleland J.L. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J. Pharm. Sci. 90 (2001) 1356-1365
23. Pfister L.A., Papaloizos M., Merkle H.P., and Gander B. Hydrogel nerve conduits produced from alginate/chitosan complexes. J. Biomed. Mater. Res. A 80 (2007) 932-937
24. Fine E.G., Decosterd I., Papaloizos M., Zurn A.D., and Aebischer P. GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap. Eur. J. Neurosci. 15 (2002) 589-601
25. De Young L.R., Burton L.E., Liu J., Powell M.F., Schmelzer C.H., and Skelton N.J. RhNGF slow unfolding is not due to proline isomerization: possibility of a cystine knot loop-threading mechanism. Protein Sci. 5 (1996) 1554-1566
26. De Young L.R., Schmelzer C.H., and Burton L.E. A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding. Protein Sci. 8 (1999) 2513-2518
27. Eng M., Ling V., Briggs J.A., Souza K., Canova-Davis E., Powell M.F., and De Young L.R. Formulation development and primary degradation pathways for recombinant human nerve growth factor. Anal. Chem. 69 (1997) 4184-4190
28. Armstrong N.A., and James K.C. Understanding Experimental Design and Interpretation in Pharmaceutics (1990), Ellis Horwood, London